Kazia Therapeutics Limited ADR (KZIA) concluded trading on Wednesday at a closing price of $9.54, with 49.53 million shares of worth about $472.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -56.44% during that period and on June 11, 2025 the price saw a gain of about 81.53%. Currently the company’s common shares owned by public are about 0.97M shares.
Stock saw a price change of 78.15% in past 5 days and over the past one month there was a price change of 167.90%. Year-to-date (YTD), KZIA shares are showing a performance of 7.80% which decreased to -23.53% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.86 but also hit the highest price of $79.00 during that period. The average intraday trading volume for Kazia Therapeutics Limited ADR shares is 29.09K. The stock is currently trading 116.27% above its 20-day simple moving average (SMA20), while that difference is up 144.20% for SMA50 and it goes to -23.85% lower than SMA200.
Kazia Therapeutics Limited ADR (NASDAQ: KZIA) currently have 0.97M outstanding shares and institutions hold larger chunk of about 4.64% of that.
The stock has a current market capitalization of $6.39M and its 3Y-monthly beta is at 2.51. It has posted earnings per share of -$29.44 in the same period. It has Quick Ratio of 0.24. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for KZIA, volatility over the week remained 30.49% while standing at 14.54% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on February 06, 2025 offering a Buy rating for the stock and assigned a target price of $3 to it. Coverage by Maxim Group stated Kazia Therapeutics Limited ADR (KZIA) stock as a Buy in their note to investors on October 14, 2021, suggesting a price target of $18 for the stock.